263 related articles for article (PubMed ID: 31801825)
1. Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa.
Sorensen AB; Tuneew I; Svensson LA; Persson E; Østergaard H; Overgaard MT; Olsen OH; Gandhi PS
J Biol Chem; 2020 Jan; 295(2):517-528. PubMed ID: 31801825
[TBL] [Abstract][Full Text] [Related]
2. Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity.
Sorensen AB; Madsen JJ; Svensson LA; Pedersen AA; Østergaard H; Overgaard MT; Olsen OH; Gandhi PS
J Biol Chem; 2016 Feb; 291(9):4671-83. PubMed ID: 26694616
[TBL] [Abstract][Full Text] [Related]
3. Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey.
Beeler DL; Aird WC; Grant MA
J Thromb Haemost; 2018 Apr; 16(4):734-748. PubMed ID: 29418058
[TBL] [Abstract][Full Text] [Related]
4. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
Persson E; Olsen OH
FEBS J; 2009 Jun; 276(11):3099-109. PubMed ID: 19490111
[TBL] [Abstract][Full Text] [Related]
5. Engineering of a membrane-triggered activity switch in coagulation factor VIIa.
Nielsen AL; Sorensen AB; Holmberg HL; Gandhi PS; Karlsson J; Buchardt J; Lamberth K; Kjelgaard-Hansen M; Ley CD; Sørensen BB; Ruf W; Olsen OH; Østergaard H
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12454-12459. PubMed ID: 29109275
[TBL] [Abstract][Full Text] [Related]
6. Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor.
Persson E; Nielsen LS; Olsen OH
Biochemistry; 2001 Mar; 40(11):3251-6. PubMed ID: 11258943
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants involved in differential behaviour between soluble tissue factor and full-length tissue factor towards factor VIIa.
Prasad R; Sen P
Phys Chem Chem Phys; 2017 Aug; 19(33):22230-22242. PubMed ID: 28799584
[TBL] [Abstract][Full Text] [Related]
9. Sequential coagulation factor VIIa domain binding to tissue factor.
Osterlund M; Persson E; Carlsson U; Freskgård PO; Svensson M
Biochem Biophys Res Commun; 2005 Dec; 337(4):1276-82. PubMed ID: 16236263
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor alters the pK(a) values of catalytically important factor VIIa residues.
Neuenschwander PF; Vernon JT; Morrissey JH
Biochemistry; 2002 Mar; 41(10):3364-71. PubMed ID: 11876644
[TBL] [Abstract][Full Text] [Related]
11. Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X.
Neuenschwander PF; Morrissey JH
J Biol Chem; 1994 Mar; 269(11):8007-13. PubMed ID: 8132522
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the interaction between the light chain of factor VIIa and tissue factor.
Persson E
FEBS Lett; 1997 Aug; 413(2):359-63. PubMed ID: 9280313
[TBL] [Abstract][Full Text] [Related]
13. Binding of Zn2+ to a Ca2+ loop allosterically attenuates the activity of factor VIIa and reduces its affinity for tissue factor.
Petersen LC; Olsen OH; Nielsen LS; Freskgård PO; Persson E
Protein Sci; 2000 May; 9(5):859-66. PubMed ID: 10850795
[TBL] [Abstract][Full Text] [Related]
14. Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor.
Carlsson K; Freskgård PO; Persson E; Carlsson U; Svensson M
Eur J Biochem; 2003 Jun; 270(12):2576-82. PubMed ID: 12787023
[TBL] [Abstract][Full Text] [Related]
15. Substrate recognition by tissue factor-factor VIIa. Evidence for interaction of residues Lys165 and Lys166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X.
Huang Q; Neuenschwander PF; Rezaie AR; Morrissey JH
J Biol Chem; 1996 Sep; 271(36):21752-7. PubMed ID: 8702971
[TBL] [Abstract][Full Text] [Related]
16. The origins of enhanced activity in factor VIIa analogs and the interplay between key allosteric sites revealed by hydrogen exchange mass spectrometry.
Rand KD; Andersen MD; Olsen OH; Jørgensen TJ; Ostergaard H; Jensen ON; Stennicke HR; Persson E
J Biol Chem; 2008 May; 283(19):13378-87. PubMed ID: 18343822
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor activates allosteric networks in factor VIIa through structural and dynamic changes.
Madsen JJ; Persson E; Olsen OH
J Thromb Haemost; 2015 Feb; 13(2):262-7. PubMed ID: 25403348
[TBL] [Abstract][Full Text] [Related]
18. The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa.
Fiore MM; Neuenschwander PF; Morrissey JH
J Biol Chem; 1994 Jan; 269(1):143-9. PubMed ID: 8276788
[TBL] [Abstract][Full Text] [Related]
19. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
20. Transition state analysis of the complex between coagulation factor VIIa and tissue factor: suggesting a sequential domain-binding pathway.
Osterlund M; Persson E; Svensson M; Carlsson U; Freskgård PO
Biochem Biophys Res Commun; 2005 Feb; 327(3):789-93. PubMed ID: 15649415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
